1. |
Epi4K Consortium & Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature, 2013, 501(7466): 217-221.
|
2. |
Mastrangelo M. Lennox-Gastaut Syndrome: a state of the art review. Neuropediatrics, 2017, 48(3): 143-151.
|
3. |
Willemsen MH, Vissers LE, Willemsen MA, et al. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J Med Genet, 2012, 49(3): 179-183.
|
4. |
Poirier K, Lebrun N, Broix L, et al. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat Genet, 2013, 45(6): 639-647.
|
5. |
Jamuar SS, Lam AT, Kircher M, et al. Somatic mutations in cerebral cortical malformations. N Engl J Med, 2014, 371(8): 733-743.
|
6. |
Vallee RB, McKenney RJ, Ori-McKenney KM. Multiple modes of cytoplasmic dynein regulation. Nat Cell Biol, 2012, 14(3): 224-230.
|
7. |
Harada A, Takei Y, Kanai Y, et al. Golgi vesiculation and lysosome dispersion in cells lacking cytoplasmic dyne in. J Cell Biol, 1998, 141(1): 51-59.
|
8. |
Harms MB, Ori-McKenney KM, Scoto M, et al. Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology, 2012, 78(22): 1714-1720.
|
9. |
Tsurusaki Y, Saitoh S, Tomizawa K, et al. A DYNC1H1 mutation causes a dominant spinal muscular atrophy with lower extremity predominance. Neurogenetics, 2012, 13(4): 327-332.
|
10. |
Vissers LE, de Ligt J, Gilissen C, et al. A de novo paradigm for mental retardation. Nat Genet, 2010, 42(12): 1109-1112.
|